We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Molecular Targets in Biliary Carcinogenesis and Implications for Therapy.
- Authors
Oyasiji, Tolutope; Zhang, Jianliang; Kuvshinoff, Boris; Iyer, Renuka; Hochwald, Steven N.
- Abstract
Biliary tract cancers (BTCs) encompass a group of invasive carcinomas, including cholangiocarcinoma (intrahepatic, perihilar, or extrahepatic), and gallbladder carcinoma. Approximately 90% of patients present with advanced, unresectable disease and have a poor prognosis. The latest recommendation is to treat advanced or metastatic disease with gemcitabine and cisplatin, although chemotherapy has recorded modest survival benefits. Comprehension of the molecular basis of biliary carcinogenesis has resulted in experimental trials of targeted therapies in BTCs, with promising results. This review addresses the emerging role of targeted therapy in the treatment of BTCs. Findings from preclinical studies were reviewed and correlated with the outcomes of clinical trials that were undertaken to translate the laboratory discoveries.
- Subjects
CELL receptors; CELLULAR signal transduction; EPIDERMAL growth factor; GENE expression; GROWTH factors; ONCOGENES; PROTEIN kinases; RNA; VASCULAR endothelial growth factors; BILE duct tumors; CONTINUING education units; DNA methylation; GENETICS; TUMOR treatment
- Publication
Oncologist, 2015, Vol 20, Issue 7, p742
- ISSN
1083-7159
- Publication type
Article
- DOI
10.1634/theoncologist.2014-0442